论文部分内容阅读
目的探讨脑出血采用吡拉西坦氯化钠注射液治疗的临床体会。方法选取2013年3月~2013年12月在我院治疗的87例脑出血患者,采用随机分组的方法进行分组及不同的治疗,治疗结束后对比观察两组临床疗效。结果研究组总有效率为90.9%,对照组总有效率为76.7%,两组差异显著,具有统计学意义(P<0.05);治疗前,两组颅压对比无显著差异,不具有统计学意义(P>0.05);治疗后,两组颅压及尿量无显著差异,不具有统计学意义(P>0.05)。结论吡拉西坦氯化钠注射液可以显著降低患者颅压,改善患者神经功能缺损,具有理想的临床应用价值。
Objective To investigate the clinical experience of intracerebral hemorrhage treated with piracetam sodium chloride injection. Methods A total of 87 patients with ICH treated in our hospital from March 2013 to December 2013 were randomly divided into groups and different treatment groups. After the treatment, the clinical efficacy of the two groups were compared. Results The total effective rate was 90.9% in the study group and 76.7% in the control group, with significant difference between the two groups (P <0.05). There was no significant difference in the intracranial pressure between the two groups before treatment Significance (P> 0.05). After treatment, there was no significant difference between the two groups in intracranial pressure and urine volume (P> 0.05). Conclusion Piracetam sodium chloride injection can significantly reduce intracranial pressure in patients with neurological deficits, and has an ideal clinical value.